Latest Press Releases
As interest in physician-guided peptide programs grows in 2026, this Enhanced Sermorelin review examines current pricing, telehealth eligibility, compounded prescription status, historical FDA context, and what performance-focused adults should verify before choosing a plan.
As interest in clinician-guided NAD+ therapy continues growing in 2026, this Enhanced NAD+ review examines current monthly pricing, prescription requirements, brand-stated injectable and liposomal options, and the medical-group, pharmacy, formulation, and refund details buyers should verify before ordering.